Zentalis Pharmaceuticals (NASDAQ:ZNTL) Earns “Buy” Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) in a research note published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $46.00 price objective on the stock. ZNTL has been the subject of several other reports. Wedbush raised their target price on Zentalis Pharmaceuticals from $12.00 […]
More Stories
Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Friday. The...
Pool (NASDAQ:POOL) Stock Rating Upgraded by StockNews.com
Pool (NASDAQ:POOL – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating...
StockNews.com Downgrades Meritage Homes (NYSE:MTH) to Sell
Meritage Homes (NYSE:MTH – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a...
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com
Equities research analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a note...
PriceSmart (NASDAQ:PSMT) Cut to Hold at StockNews.com
StockNews.com downgraded shares of PriceSmart (NASDAQ:PSMT – Free Report) from a buy rating to a hold rating in a research...
Clearfield (NASDAQ:CLFD) Rating Lowered to “Sell” at StockNews.com
Clearfield (NASDAQ:CLFD – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell”...